Takeshi Hisada

Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I–III nonsmall cell lung cancer

Kyoichi Kaira, Noboru Oriuchi, Hisao Imai et al. · British Journal of Cancer · 2008 · 214 citations · Full text

Medicine, Cancer Biology, Oncology +15

Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC

Kyoichi Kaira, Tetsuya Higuchi, Ichiro Naruse et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 191 citations

Medicine, Nuclear Medicine, Oncology +15

Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma

Haruka Aoki, Takeshi Hisada, Tamotsu Ishizuka et al. · Biochemical and Biophysical Research Communications · 2008 · 170 citations

Life Sciences, Immunology, Pharmacology +11

<scp>l</scp>‐type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms

Kyoichi Kaira, Noboru Oriuchi, Hisao Imai et al. · Cancer Science · 2008 · 160 citations · Full text

Medicine, Cancer Biology, Oncology +16

Phase II prospective study of the efficacy of gefitinib for the treatment of stage III/IV non-small cell lung cancer with EGFR mutations, irrespective of previous chemotherapy

Noriaki Sunaga, Yoshio Tomizawa, Noriko Yanagitani et al. · Lung Cancer · 2007 · 129 citations

Medicine, Oncology, Pharmacology +16